Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Avg
|
|
New words:
Allovectin, arising, assay, Australia, Australian, autoimmune, BBB, benchmark, Bilinsky, billable, BioVex, Boston, Celgene, Centre, compound, CyMVectinTM, cytofectin, digit, dorsal, eighty, entirety, evidenced, family, Fast, ganglia, guinea, Halozyme, heightened, Henry, Hope, Hospitalier, Igor, inflammatory, insolvency, insolvent, Integrated, IPPOX, Jackson, leader, light, Lincoln, lost, matrix, meantime, MIT, mL, Moscow, nonexclusively, overallotment, pig, Plexxikon, prevalence, ratified, resolution, rolling, root, shedding, substantive, suspected, Symyx, thereunder, Track, TransVaxTM, uncured, underscore, underwriting, unenforceable, Universitaire, Untied, vagina, visit
Removed:
Academy, Africa, Amsterdam, Andrew, anthrax, Aranesp, assignment, attach, attenuated, Baxter, Biogen, boosting, Bracken, built, Captain, carcinoembryonic, CEA, clade, coat, conference, consistent, consolidated, create, direction, discontinued, diversification, duPont, Enbrel, encode, endothelial, env, epidermal, Epogen, federally, fermenter, fetal, FluMist, gag, GFE, Gilead, Guttadauro, Guttadaurojoined, Hg, Idec, improve, inhaled, installed, Kevin, Kineret, Lupron, Medarex, middle, modality, Montreal, nef, Network, North, optimization, organization, outer, overseeing, oxygen, perfusion, physiologically, point, pol, polyfunctional, preservation, pressure, Prevacid, priming, promote, publication, radioimmunotherapy, reaching, receptor, recognizedde, remanufacture, retained, returned, reveal, reviewed, Rochester, run, seronegative, shipment, Subcommittee, subcontract, subcontractor, subgroup, subtype, syndrome, synthetically, Tap, tendering, tolerated, Topic, tour, Towne, umbrella, variation, Vestar, volume, weaponized, Wistar, world, Zevalin
Filing tables
Filing exhibits
- 10-K Annual report
- 10.6 First Amendment Dated December 17, 2010 to Consulting Agreement
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of Vijay B. Samant, Chief Executive Officer
- 31.2 Certification of Jill M. Broadfoot, Chief Financial Officer
- 32.1 Certification of Vijay B. Samant, Chief Executive Officer
- 32.2 Certification of Jill M. Broadfoot, Chief Financial Officer
Related press release
FRTX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following registration statements:
| 1) | Registration Statements on Form S-3 (333-159103 and 333-164476) of Vical Incorporated, and |
| 2) | Registration Statements on Form S-8 (33-60826, 33-60824, 33-81602, 33-81600, 33-87972, 333-30181, 333-80681, 333-60293, 333-66254, 333-97019, 333-107581, 333-116951, 333-135266, 333-143885, and 333-169344) of Vical Incorporated; |
of our reports dated March 4, 2011, with respect to the financial statements of Vical Incorporated, and the effectiveness of internal control over financial reporting of Vical Incorporated, included in this Annual Report (Form 10-K) of Vical Incorporated for the year ended December 31, 2010.
/s/ ERNST & YOUNG LLP
San Diego, California
March 4, 2011